Patents/Assignees

Curevac SE

55 patents in portfolio

US11865084utility2024
MERS Coronavirus Vaccine
0 cites
US11786590utility2023
Rotavirus Vaccines
0 cites
US11761009utility2023
Artificial Nucleic Acid Molecules for Improved Protein Expression
0 cites
US11739335utility2023
Nucleic Acids Encoding Crispr-associated Proteins and Uses Thereof
0 cites
US11697816utility2023
Artificial Nucleic Acid Molecules
0 cites
US11690910utility2023
Pharmaceutical Composition Comprising a Polymeric Carrier Cargo Complex and at Least One Protein or Peptide Antigen
0 cites
US11692002utility2023
RNA Sequence Adaptation
0 cites
US11684665utility2023
Method for Producing RNA Molecule Compositions
0 cites
US11672856utility2023
Vaccination in Newborns and Infants
0 cites
US11608513utility2023
Method for Adding Cap Structures to RNA Using Immobilized Enzymes
0 cites
US11596686utility2023
Coronavirus Vaccine
0 cites
US11596699utility2023
RNA Encoding an Antibody
0 cites
US11576966utility2023
Coronavirus Vaccine
0 cites
US11559570utility2023
Prime-boost Regimens Involving Administration of at Least One Mrna Construct
0 cites
US11542490utility2023
Rnas for Wound Healing
0 cites

← PreviousPage 3 of 3